U-NWBO

Q:NWBO - NORTHWEST BIOTHERAPEUTICS INC - https://www.nwbio.com/

13:30:33 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NWBO - Q	not subscribed					0.19637	-0.00453	-2.3	1,307.7	246	196	0.20 0.2019 0.194	0.368 0.1825	13:09:52	Jun 01	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTCQB -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 196

More trades...

Time ET	Ex	Price	Change	Volume
13:09:52	Q	0.19637	-0.00453	5,000
13:07:00	Q	0.1969	-0.004	5,000
13:01:43	Q	0.19532	-0.00558	5,000
13:01:43	Q	0.195	-0.0059	1
12:49:57	Q	0.196	-0.0049	5,000
12:49:45	Q	0.196	-0.0049	8,000
12:48:59	Q	0.196	-0.0049	2,000
12:47:45	Q	0.196	-0.0049	25,000
12:47:38	Q	0.1961	-0.0048	5,000
12:40:34	Q	0.197145	-0.003755	2,500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2026-06-01 08:30	U:NWBO	News Release200	How Advanced Drug Delivery Could Improve Existing Cancer Treatments
2026-05-11 08:30	U:NWBO	News Release200	CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
2026-04-30 12:30	U:NWBO	News Release200	Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
2026-04-21 09:30	U:NWBO	News Release200	Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
2025-11-20 14:40	U:NWBO	News Release200	Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
2025-10-24 12:03	U:NWBO	News Release200	Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
2025-08-27 12:39	U:NWBO	News Release200	Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
2025-08-18 12:37	U:NWBO	News Release200	Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
2025-06-11 12:49	U:NWBO	News Release200	Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments

Date ET

Symbol

Type

Headline

2026-06-01 08:30

U:NWBO

News Release

How Advanced Drug Delivery Could Improve Existing Cancer Treatments

2026-05-11 08:30

U:NWBO

News Release

CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities